These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15645184)

  • 1. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.
    Robinson DO; Hammans SR; Read SP; Sillibourne J
    Hum Genet; 2005 Mar; 116(4):267-71. PubMed ID: 15645184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation.
    Robinson DO; Wills AJ; Hammans SR; Read SP; Sillibourne J
    J Med Genet; 2006 May; 43(5):e23. PubMed ID: 16648376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.
    van der Sluijs BM; van Engelen BG; Hoefsloot LH
    Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
    Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
    Bae JS; Ki CS; Kim JW; Kim BJ
    J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation.
    Robinson DO; Hilton-Jones D; Mansfield D; Hildebrand GD; Marks S; Mechan D; Ramsay J
    Neuromuscul Disord; 2011 Nov; 21(11):809-11. PubMed ID: 21742497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation and haplotype analysis of oculopharyngeal muscular dystrophy in Thai patients.
    Pulkes T; Papsing C; Busabaratana M; Dejthevaporn C; Witoonpanich R
    J Clin Neurosci; 2011 May; 18(5):674-7. PubMed ID: 21316245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
    Brais B
    Cytogenet Genome Res; 2003; 100(1-4):252-60. PubMed ID: 14526187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.
    Goh KJ; Wong KT; Nishino I; Minami N; Nonaka I
    Neuromuscul Disord; 2005 Mar; 15(3):262-4. PubMed ID: 15725589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation.
    Davies JE; Sarkar S; Rubinsztein DC
    Hum Mol Genet; 2008 Apr; 17(8):1097-108. PubMed ID: 18178579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy.
    Nakamoto M; Nakano S; Kawashima S; Ihara M; Nishimura Y; Shinde A; Kakizuka A
    Arch Neurol; 2002 Mar; 59(3):474-7. PubMed ID: 11890856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of
    Cruz-Aguilar M; Guerrero-de Ferran C; Tovilla-Canales JL; Nava-Castañeda A; Zenteno JC
    J Investig Med; 2017 Mar; 65(3):705-708. PubMed ID: 27980005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GCG expansion (GCG)₁₁ in polyadenylate-binding protein nuclear 1 gene caused oculopharyngeal muscular dystrophy in a Chinese family.
    Ye J; Zhang H; Zhou Y; Wu H; Wang C; Shi X
    Mol Vis; 2011; 17():1350-4. PubMed ID: 21647273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.
    Nishii YS; Noto YI; Yasuda R; Kitaoji T; Ashida S; Tanaka E; Minami N; Nishino I; Mizuno T
    BMC Neurol; 2021 Jul; 21(1):265. PubMed ID: 34225694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculopharyngeal muscle dystrophy: fine structure and mRNA expression levels of PABPN1.
    Schröder JM; Klossok T; Weis J
    Clin Neuropathol; 2011; 30(3):94-103. PubMed ID: 21545772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.
    Bhattacharjee RB; Zannat T; Bag J
    Cell Biol Int; 2012 Aug; 36(8):697-704. PubMed ID: 22519734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.